Intralesional triamcinolone acetonide injection versus incision and curettage for primary chalazia a prospective, randomized study Guy J. Ben Simon, Nachum.

Slides:



Advertisements
Similar presentations
TESTUPLOAD. TORSIONAL PHACOEMULSIFICATION In January 2006 Alcon Surgical incorporated Ozil torsional into the Infiniti Vision System. Unlike the conventional.
Advertisements

Comparison of Visual Outcomes With Toric IOL and With Limbal Relaxing Incisions in Cataract Surgery Eriko Fukuyama, MD Fukuyama Eye Clinic Fukuoka, Japan.
Review of clinical anatomy & physiology of the eyelids & common infective and inflammatory disorders of the eyelids Dr. Ayesha S Abdullah
Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
World Cornea Congress VII – Electronic Poster Season Tse Wing Yeung, MBBS, FRANZCO Ronan Conlon, MD; Joshua Teichman, MD, FRCSC; Setareh Ziai, MD, FRCSC;
Definition: Localized suppurative inflammation of hair follicle and its associated gland of zeis at lid margin.
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
The Diabetic Retinopathy Clinical Research Network Repeated Intravitreous Ranibizumab Injections for DME and Risk of Sustained IOP Elevation or Need for.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Topography-Guided Photorefractive Keratectomy (TG-PRK) for Keratoconus (KC) with Simultaneous Collagen Cross-linking (CXL) Using High-Resolution Excimer.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Aref.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Dry Eyes and Blepharitis Mitch Menage Consultant Eye Surgeon Leeds Teaching Hospitals Trust Mitch Menage Consultant Eye Surgeon Leeds Teaching Hospitals.
Nizar S Abdelfattah, M.D.1, Marina Israel2, Nermin Osman, M.D.3,
Clinical Pathology Case Chalazion
V G S Brar MD Dilraj Grewal MD Rajeev Jain, MD SPS Grewal MD Postoperative IOP and Anterior Chamber Inflammation Following Intracameral Injection of Pilocarpine.
Design: A randomized, prospective, double-blind cohort followed for 16 weeks RenehaVis Original Study 50 DMW 50 HMW 50 LMW 50 Placebo.
Effects of IOP Lowering Agents on Myopic Regression after Refractive Surgery Lim, Taehyung M.D., Hong, So Jin M.D., Cho, Beom Jin M.D., Ph.D. Chung Kyu-Hyung.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew.
Laser-Ranibizumab-Triamcinolone for DME Study DRCR.net Protocol I
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
“OUR EXPERIENCE OF SECONDARY IOLS - SCLERAL FIXATION v/sAC IOL DR. RUPAM DESAI ROTARY EYE INSTITUTE NAVSARI INDIA (Author has no financial interest)
Combined Phacoemulsification and Ahmed Glaucoma Drainage Implant Surgery Leonidas Traipe, M.D. Felipe Valenzuela, M.D. Carlos Nieme, M.D Juan Stoppel,
A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.
Financial Disclosure: None
Results of Collagen Crosslinking followed by posterior chamber toric implantable collamer lens implantation in patients with Keratoconus & High Myopia.
M. Vokrojova MD, M. Vokrojova MD, D. Sivekova MD, L. Wagnerova MD D. Sivekova MD, L. Wagnerova MD Prof. P. Kuchynka MD, PhD Prof. P. Kuchynka MD, PhD The.
«ASTANA VISION», ASTANA city, Republic of KAZAKHSTAN Igor Remesnikov, Vladimir Kim Refractive and visual outcomes after Femto-SubBowman’s Keratomileusis.
EENT Blueprint PANCE Blueprint. Eye Disorders Blepharitis Blepharitis is characterized by inflammation of the eyelids There is anterior and posterior.
REFRACTIVE OUTCOMES WITH TORIC ICL IMPLANTS CHIEF AUTHOR: Dr. D.RAMAMURTHY CO – AUTHOR: Dr. R.CHITRA The authors have no financial interest in the subject.
Refractec ViewPoint™ CK System for the Treatment of Spherical Hyperopia Sheryl Berman, MD Medical Officer FDA/CDRH/ODE/DOED.
Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,
PHACO-TRAB VERSUS PHACO ONLY IN EYES WITH ADVANCED OR END-STAGE GLAUCOMA WITH CONTROLLED INTRAOCULAR PRESSURE AND VISUALLY SIGNIFICANT CATARACT Liaska.
Vulvodynia Research Studies: National Institutes of Health.
Nang-Hee Song(MD) 1, Jae-Woong Koh (MD/PhD) 1, Gil-Joong Yoon (MD/PhD) 2 Department of Ophthalmology, Chosun University College of Medicine, Gwangju, Republic.
Outcome of cataract surgery in Scleritis patients Bhupesh Bagga Cornea & Anterior Segment Department L.V.Prasad Eye Institute, Hyderabad,India Financial.
Evaluation of Efficacy and Safety of Intracorneal Ring Segment (Intacs SK) in Keratoconus Abdulrahman Al-Muammar, MD, FRCSC I have no financial interest.
Keyondra Gamble. Ophthalmologist An ophthalmologist is a doctor specializing in the diagnosis and treatment of diseases of the eye.
10 year follow up of LASIK surgery for low to high levels of myopia Qasim Qasem FRCS, Caitriona Kirwan MRCOpth, Michael O’Keefe FRCS. Institutional Affiliations:
Sponsored by the National Eye Institute,
Visual and IOP Outcomes after PRK in Pigment Dispersion Syndrome [Poster Number: P190] Kraig S. Bower, Denise A. Sediq, Charles D. Coe, Keith Wroblewski,
Efficacy and Safety of the Ex-PRESS Glaucoma Mini-Shunt with Intraoperative 5-Fluorouracil ASCRS 2009 – San Francisco A. Balashanmugam, MD, L. Farrokh-Siar,
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
 Postoperative care starts with the application of an adequate internal and external nose dressing.  The follow-up does not end with removal of the.
Phase 2 Evaluation of Intravitreal Bevacizumab for DME Sponsored by the National Eye Institute, National Institutes of Health, U.S. Department of Health.
Comparison of Efficacy of 0.05% Cyclosporine Ophthalmic Emulsion
Comparing laser in situ keratomileusis and photorefractive keratectomy in different eyes of the same patient. Joseph Frucht-Pery, MD, Faik Orucov, MD*,
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
UC Davis Long-Term Outcomes of the Boston Type I Keratoprosthesis Jennifer Li, M.D., Mark Greiner, M.D. Ana Carolina Vieira, M.D. Mark Mannis, M.D. University.
Femtosecond-Assisted Lamellar Corneal Tattooing for Visual Disturbances from Traumatic and Post-Surgical Iris Defects Duna Raoof, MD Roberto Pineda, MD.
mild Decompression for the Treatment of Lumbar Spinal Stenosis
Comparing Factors Affecting Surgically Induced Astigmatism
PTERYGIUM AND TOPICAL BEVACIZUMAB: A 2 YEAR FOLLOW UP DR. ADITYA SUDHALKAR,M.S. DR. ANAND SUDHALKAR,M.S. The authors have no financial interest in this.
First 25 Descemet Membrane Endothelial Keratoplasty (DMEK) Outcomes for an Experienced DSAEK Surgeon Authors: Victoria Epstein, MS.,DO, Josh Wallsh, MS-III,
Custom Topographic Neutralizing Technique (TNT) with Topographically-Guided (TG) laser to correct complications David T.C Lin Simon Holland ASCRS 2010.
Division of Plastic Surgery University of Puerto Rico Norma I. Cruz, MD Nothing to disclose.
A Paul, C Louize,S Shafquat Dudley Hospitals NHS Foundation Trust
Y. Athanasiadis, G. Nithyanandrajah, D. Bishop, P. Scollo, A
A NEW INTRACANALICULAR DEVICE TO TREAT OPEN-ANGLE GLAUCOMA
PERIPHERAL CORNEAL INFLAMMATION
Evaluation of Akreos AO micro-incision IOL, implantation in 350 eyes :
Protocol U Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involved DME Following Anti-VEGF.
Common Eye Problems in General Practice
Kyoto Prefectural University of Medicine
O Beltaief, Kh Errais, W Zbiba, A Ouertani.
BAT for HFrEF Trial design: Patients with chronic systolic HF were randomized in a 1:1 fashion to either baroreceptor activation therapy (BAT) or control.
Cheil Eye Hospital , Daegu, Korea
Safety and Efficacy of Mapracorat Ophthalmic Suspension in the Treatment of Inflammation Following Cataract Surgery: Adaptive Design Study Timothy L.
Presentation transcript:

Intralesional triamcinolone acetonide injection versus incision and curettage for primary chalazia a prospective, randomized study Guy J. Ben Simon, Nachum Rosen, Mordechai Rosner, Abraham Spierer Goldschleger Eye Institute Am J Ophthalmol 2011; 151:

Chalazia Plugged meibomian gland Chronic lipogranulomatous inflammation Local eye symptoms: irritation and inflammation Cosmetic disfigurement Larger lesions can induce mechanical ptosis corneal astigmatism Self limited in 25-50%

Treatment modalities Eyelid hygiene with warm compresses Antibiotic / steroid ophthalmic ointment Systemic tetracycline chronic blepharitis acne rosacea Surgical treatments steroids injections CO 2 laser excision and curettage total excision BTX-A

Steroid injection Intralesional or sub-cutaneously Reported success and resolution in 50-95% Simple and effective treatment serious adverse effects

Purpose To evaluate the safety and efficacy of intralesional triamcinolone acetonide (TA) injection in primary and recurrent chalazia 147 patients with primary or recurrent chalazia (155 cases)

Results Most of the patients received 1-2 injections Average time to resolution 2.5 weeks Patients who failed to respond 1-2 TA inj. more likely to result in failure to respond to further injections or in surgical excision Patients with blepharitis required on average more injections to resolution 2±1.3 vs. 1.4±1

Results

Conclusions Intralesional TA effective in lesion regression Chalazia that fail to respond to 2 or 3 injections most likely will necessitate surgical excision Should be considered as a first treatment in cases where diagnosis is straightforward

Resolution >80%

Partial resolution (<50%)

Prospective study Intralesional TA (4mg) vs. Incision and curettage for primary chalazia Randomized

Demographics Incision & Curettage TAP N4252 Age(years) GenderMale (ns) Female1729 Duration(months) (ns) LocationRUL1518 RLL (ns) LUL1113 LLL812

ResolutionFailureP Incision & curettage 33 (79%)90.8 (ns) TA42 (81%)10 Success (Chi-Square)

Resolution TA 1 week post RLL TA injection

Resolution TA 2 weeks post LLL TA injection

Resolution TA 1 week post LUL TA injection

Failed TA  I & C A – pre-treatment, B – 1 w post TA, C – 5 w post TA, D – post I & C

Failed I & C  TA 1w post I & C 1w post TA Pre-op.

Incision & Curettage TA Visual acuity Pre-op.20/20 Post-op.20/20 P valuens IOP mmHg Pre-op Post-op P valuens 2 nd outcome measures

TA injection Average time to resolution 5 days Average injections number (92%)- single injection 4 (8%)- two injections Failed cases > older 52 yrs vs. 35 yrs (P=0.001)

TA precipitates 6/52 (11.5%)

Conclusions TA injections as effective as incision & curettage for primary chalazia Most lesions resolve with 1 injection Can be efficiently applied after failed I & C TA precipitates occur in 11% and resolve spontaneously within weeks to months